Found 12 matching trials
Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer PHASE2 According to the investigator's judgment, there are concomitant diseases th...
Show More Location
Shengjing Hospital of China Medical University
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer PHASE2 This prospective, response-guided phase II study investigates individualize...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05) PHASE2 This study is a prospective, single arm, multi-center clinical trial. The p...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study PHASE2 This clinical trial aim to evaluate the efficacy and safety of Pyrotinib in...
Show More Location
Multiple Locations
Learn More & Join Trial
Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer PHASE2 This is a multicenter, open-label, single-arm, prospective, phase II study....
Show More Location
Multiple Locations
Learn More & Join Trial
Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer PHASE2 The study is being conducted to evaluate the efficacy, and safety of pyroti...
Show More Location
Multiple Locations
Learn More & Join Trial
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer PHASE2 This study aims to evaluate the efficacy and safety of pyrotinib in combina...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ± Chemotherapy in Patients With Advanced Digestive System Tumors PHASE2 This is a prospective, open-label, exploratory, phase II basket clinical tr...
Show More Learn More & Join Trial